Local Modulated Electro-Hyperthermia in Combination With Traditional Chinese Medicine Versus Intraperitoneal Chemoinfusion in Treatment of Peritoneal Carcinomatosis With Malignant Ascites: ... View Homepage


Ontology type: schema:MedicalStudy     


Clinical Trial Info

YEARS

2014-2015

ABSTRACT

This trial studies efficacy and safety of combination of modulated electro-hyperthermia (mEHT) with Traditional Chinese Medicine (TCM) in treatment of peritoneal carcinomatosis with malignant ascites versus standard chemoinfusion (CDDP+5FU). Detailed Description Conservative treatment of peritoneal carcinomatosis with malignant ascites (PCMA) is based on chemoinfusion with its inherent toxicity. There is a strong demand for a safe and non-toxic method of treatment of PCMA. The new technology of modulated electro-hyperthermia (mEHT) has proven efficacy in many advanced cancers with minimal side effects and synergy with Traditional Chinese Medicine (TCM). TCM has a long history of application at advanced cancer as a symptomatic treatment and enhancer of the general resistance of the organism. Shi Pi Decoction is supposed to be the optimum co-treatment of PCMA according to principles of TCM. Intraperitoneal chemoinfusion (IPCI) with cisplatin and fluorouracil is a widespread standard treatment of PCMA in China. This randomized II phase trial studies efficacy and safety of combination of mEHT with TCM in treatment of PCMA versus standard IPCI (CDDP+5FU). More... »

URL

https://clinicaltrials.gov/show/NCT02638051

Related SciGraph Publications

JSON-LD is the canonical representation for SciGraph data.

TIP: You can open this SciGraph record using an external JSON-LD service: JSON-LD Playground Google SDTT

[
  {
    "@context": "https://springernature.github.io/scigraph/jsonld/sgcontext.json", 
    "about": [
      {
        "id": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/3142", 
        "inDefinedTermSet": "http://purl.org/au-research/vocabulary/anzsrc-for/2008/", 
        "type": "DefinedTerm"
      }
    ], 
    "description": "This trial studies efficacy and safety of combination of modulated electro-hyperthermia (mEHT) with Traditional Chinese Medicine (TCM) in treatment of peritoneal carcinomatosis with malignant ascites versus standard chemoinfusion (CDDP+5FU).\n\nDetailed Description\nConservative treatment of peritoneal carcinomatosis with malignant ascites (PCMA) is based on chemoinfusion with its inherent toxicity. There is a strong demand for a safe and non-toxic method of treatment of PCMA. The new technology of modulated electro-hyperthermia (mEHT) has proven efficacy in many advanced cancers with minimal side effects and synergy with Traditional Chinese Medicine (TCM). TCM has a long history of application at advanced cancer as a symptomatic treatment and enhancer of the general resistance of the organism. Shi Pi Decoction is supposed to be the optimum co-treatment of PCMA according to principles of TCM. Intraperitoneal chemoinfusion (IPCI) with cisplatin and fluorouracil is a widespread standard treatment of PCMA in China. This randomized II phase trial studies efficacy and safety of combination of mEHT with TCM in treatment of PCMA versus standard IPCI (CDDP+5FU).", 
    "endDate": "2015-12-01T00:00:00Z", 
    "id": "sg:clinicaltrial.NCT02638051", 
    "keywords": [
      "IN", 
      "Chinese medicine", 
      "peritoneal carcinomatosis", 
      "malignant ascites", 
      "Phase II", 
      "efficacy", 
      "Chinese Traditional Medicine", 
      "conservative treatment", 
      "inherent toxicity", 
      "strong demand", 
      "method", 
      "technology", 
      "proven efficacy", 
      "advanced cancer", 
      "minimal side effect", 
      "synergy", 
      "long history", 
      "symptomatic treatment", 
      "enhancer", 
      "resistance", 
      "organism", 
      "shi", 
      "co-treatment", 
      "principle", 
      "cisplatin", 
      "Fluorouracil", 
      "standard treatment", 
      "safety"
    ], 
    "name": "Local Modulated Electro-Hyperthermia in Combination With Traditional Chinese Medicine Versus Intraperitoneal Chemoinfusion in Treatment of Peritoneal Carcinomatosis With Malignant Ascites: A Phase II Randomized Trial", 
    "sameAs": [
      "https://app.dimensions.ai/details/clinical_trial/NCT02638051"
    ], 
    "sdDataset": "clinical_trials", 
    "sdDatePublished": "2019-03-07T15:26", 
    "sdLicense": "https://scigraph.springernature.com/explorer/license/", 
    "sdPublisher": {
      "name": "Springer Nature - SN SciGraph project", 
      "type": "Organization"
    }, 
    "sdSource": "file:///pack/app/us_ct_data_00020.json", 
    "startDate": "2014-01-01T00:00:00Z", 
    "subjectOf": [
      {
        "id": "https://doi.org/10.1002/bjs.7586", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1001230297"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1186/s12885-015-1690-2", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1013305391", 
          "https://doi.org/10.1186/s12885-015-1690-2"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s12192-014-0523-6", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1027396034", 
          "https://doi.org/10.1007/s12192-014-0523-6"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00066-014-0617-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1048040971", 
          "https://doi.org/10.1007/s00066-014-0617-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "sg:pub.10.1007/s00066-009-1903-1", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1053683126", 
          "https://doi.org/10.1007/s00066-009-1903-1"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.4240/wjgs.v4.i4.87", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1072397873"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3978/j.issn.2224-5820.2013.04.05", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1079066786"
        ], 
        "type": "CreativeWork"
      }, 
      {
        "id": "https://doi.org/10.3892/mco.2017.1221", 
        "sameAs": [
          "https://app.dimensions.ai/details/publication/pub.1084800139"
        ], 
        "type": "CreativeWork"
      }
    ], 
    "type": "MedicalStudy", 
    "url": "https://clinicaltrials.gov/show/NCT02638051"
  }
]
 

Download the RDF metadata as:  json-ld nt turtle xml License info

HOW TO GET THIS DATA PROGRAMMATICALLY:

JSON-LD is a popular format for linked data which is fully compatible with JSON.

curl -H 'Accept: application/ld+json' 'https://scigraph.springernature.com/clinicaltrial.NCT02638051'

N-Triples is a line-based linked data format ideal for batch operations.

curl -H 'Accept: application/n-triples' 'https://scigraph.springernature.com/clinicaltrial.NCT02638051'

Turtle is a human-readable linked data format.

curl -H 'Accept: text/turtle' 'https://scigraph.springernature.com/clinicaltrial.NCT02638051'

RDF/XML is a standard XML format for linked data.

curl -H 'Accept: application/rdf+xml' 'https://scigraph.springernature.com/clinicaltrial.NCT02638051'


 

This table displays all metadata directly associated to this object as RDF triples.

73 TRIPLES      15 PREDICATES      50 URIs      37 LITERALS      1 BLANK NODES

Subject Predicate Object
1 sg:clinicaltrial.NCT02638051 schema:about anzsrc-for:3142
2 schema:description This trial studies efficacy and safety of combination of modulated electro-hyperthermia (mEHT) with Traditional Chinese Medicine (TCM) in treatment of peritoneal carcinomatosis with malignant ascites versus standard chemoinfusion (CDDP+5FU). Detailed Description Conservative treatment of peritoneal carcinomatosis with malignant ascites (PCMA) is based on chemoinfusion with its inherent toxicity. There is a strong demand for a safe and non-toxic method of treatment of PCMA. The new technology of modulated electro-hyperthermia (mEHT) has proven efficacy in many advanced cancers with minimal side effects and synergy with Traditional Chinese Medicine (TCM). TCM has a long history of application at advanced cancer as a symptomatic treatment and enhancer of the general resistance of the organism. Shi Pi Decoction is supposed to be the optimum co-treatment of PCMA according to principles of TCM. Intraperitoneal chemoinfusion (IPCI) with cisplatin and fluorouracil is a widespread standard treatment of PCMA in China. This randomized II phase trial studies efficacy and safety of combination of mEHT with TCM in treatment of PCMA versus standard IPCI (CDDP+5FU).
3 schema:endDate 2015-12-01T00:00:00Z
4 schema:keywords Chinese Traditional Medicine
5 Chinese medicine
6 Fluorouracil
7 IN
8 Phase II
9 advanced cancer
10 cisplatin
11 co-treatment
12 conservative treatment
13 efficacy
14 enhancer
15 inherent toxicity
16 long history
17 malignant ascites
18 method
19 minimal side effect
20 organism
21 peritoneal carcinomatosis
22 principle
23 proven efficacy
24 resistance
25 safety
26 shi
27 standard treatment
28 strong demand
29 symptomatic treatment
30 synergy
31 technology
32 schema:name Local Modulated Electro-Hyperthermia in Combination With Traditional Chinese Medicine Versus Intraperitoneal Chemoinfusion in Treatment of Peritoneal Carcinomatosis With Malignant Ascites: A Phase II Randomized Trial
33 schema:sameAs https://app.dimensions.ai/details/clinical_trial/NCT02638051
34 schema:sdDatePublished 2019-03-07T15:26
35 schema:sdLicense https://scigraph.springernature.com/explorer/license/
36 schema:sdPublisher N171696af70e84c1c845dd13df316e2db
37 schema:startDate 2014-01-01T00:00:00Z
38 schema:subjectOf sg:pub.10.1007/s00066-009-1903-1
39 sg:pub.10.1007/s00066-014-0617-1
40 sg:pub.10.1007/s12192-014-0523-6
41 sg:pub.10.1186/s12885-015-1690-2
42 https://doi.org/10.1002/bjs.7586
43 https://doi.org/10.3892/mco.2017.1221
44 https://doi.org/10.3978/j.issn.2224-5820.2013.04.05
45 https://doi.org/10.4240/wjgs.v4.i4.87
46 schema:url https://clinicaltrials.gov/show/NCT02638051
47 sgo:license sg:explorer/license/
48 sgo:sdDataset clinical_trials
49 rdf:type schema:MedicalStudy
50 N171696af70e84c1c845dd13df316e2db schema:name Springer Nature - SN SciGraph project
51 rdf:type schema:Organization
52 anzsrc-for:3142 schema:inDefinedTermSet anzsrc-for:
53 rdf:type schema:DefinedTerm
54 sg:pub.10.1007/s00066-009-1903-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1053683126
55 https://doi.org/10.1007/s00066-009-1903-1
56 rdf:type schema:CreativeWork
57 sg:pub.10.1007/s00066-014-0617-1 schema:sameAs https://app.dimensions.ai/details/publication/pub.1048040971
58 https://doi.org/10.1007/s00066-014-0617-1
59 rdf:type schema:CreativeWork
60 sg:pub.10.1007/s12192-014-0523-6 schema:sameAs https://app.dimensions.ai/details/publication/pub.1027396034
61 https://doi.org/10.1007/s12192-014-0523-6
62 rdf:type schema:CreativeWork
63 sg:pub.10.1186/s12885-015-1690-2 schema:sameAs https://app.dimensions.ai/details/publication/pub.1013305391
64 https://doi.org/10.1186/s12885-015-1690-2
65 rdf:type schema:CreativeWork
66 https://doi.org/10.1002/bjs.7586 schema:sameAs https://app.dimensions.ai/details/publication/pub.1001230297
67 rdf:type schema:CreativeWork
68 https://doi.org/10.3892/mco.2017.1221 schema:sameAs https://app.dimensions.ai/details/publication/pub.1084800139
69 rdf:type schema:CreativeWork
70 https://doi.org/10.3978/j.issn.2224-5820.2013.04.05 schema:sameAs https://app.dimensions.ai/details/publication/pub.1079066786
71 rdf:type schema:CreativeWork
72 https://doi.org/10.4240/wjgs.v4.i4.87 schema:sameAs https://app.dimensions.ai/details/publication/pub.1072397873
73 rdf:type schema:CreativeWork
 




Preview window. Press ESC to close (or click here)


...